Market capitalization | $1.28b |
Enterprise Value | $3.37b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 14.69 |
EV/Sales (TTM) EV/Sales | 1.03 |
P/S ratio (TTM) P/S ratio | 0.39 |
P/B ratio (TTM) P/B ratio | 0.83 |
Revenue growth (TTM) Revenue growth | 4.49% |
Revenue (TTM) Revenue | $3.26b |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
9 Analysts have issued a AdaptHealth Corp - Ordinary Shares - Class A forecast:
9 Analysts have issued a AdaptHealth Corp - Ordinary Shares - Class A forecast:
Sep '24 |
+/-
%
|
||
Revenue | 3,263 3,263 |
4%
4%
|
|
Gross Profit | 482 482 |
43%
43%
|
|
EBITDA | 697 697 |
9%
9%
|
EBIT (Operating Income) EBIT | 290 290 |
78%
78%
|
Net Profit | -218 -218 |
49%
49%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses providing sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.
Head office | United States |
CEO | Suzanne Foster |
Employees | 10,700 |
Founded | 2012 |
Website | www.adapthealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.